Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients Intensive Del Mar Fernández de Gatta García M, Revilla N, Calvo MV, Domínguez-Gil A, Sánchez Navarro A. Care Medicine 33:279-285. FI: 5.168 (Q1) Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes Gutiérrez Millán C, Zarzuelo Castañeda A, González López F, Sayalero Marinero ML, Lanao JM. Journal of Antimicrobial Chemotherapy 61(2):375-381. FI: 4.352 (Q1) Recents advances in delivery systems of anti-HIV-1 therapy Lanao JM, Briones E, Colino CI. Journal of Drug Targeting 15(1):21-36. FI: 2.885 (Q2) Sodium salicylate prevents paraquat-induced apoptosis in the rat lung Dinis-Oliveira RJ, Sousa C, Remião F, Duarte JA, Ferreira R, Sánchez Navarro A, Bastos ML, Carvalho F. Free radical biology and medicine 43(1):48-61. FI: 6.081 (Q1) Delivery systems to increase the selectivity of antibiotics in phagocytic cells Briones E, Colino CI, Lanao JM. Journal of Controlled Release 125(3):210-227. FI: 5.949 (Q1) Efavirenz-rifampicin interaction: therapeutic drug monitorng to efavirenz dosage optimization in HIV/TBC patients Cabrera SE, Cordero M, Iglesias A, Valverde MP, Domínguez-Gil A, García MJ. AIDS 22:2549-2551. FI: 4.909 (Q1) Development and validation of an HPLC method for vancomycin and its application to a pharmacokinetic study Jesús Valle MJ, López FG, Navarro AS. Journal of pharmaceutical and biomedical 48:835-839. FI: 2.453 (Q2) Pulmonary versus systemic delivery of levofloxacin. The isolated lung of the rat as experimental approach of assessing pulmonary inhalation De Jesús Valle MJ, López FG, Sánchez Navarro A. Pulmonary pharmacology & Therapeutics 2/21:298-303. FI: 2.024 (Q3) Evaluación de los sistemas de utilización de medicamentos en los hospitales españoles 2007 Otero López MJ, Martín Muñoz MR, Castaño Rodríguez B, Palomo Cobos L, Cajaraville Ordoñana G, Codina Jané C, Martínez Cutillas J, Pérez Encinas M, Salvador Garrido P, Santos Rubio MD. Grupo de Trabajo MSSA. Medical Clinical 131(Suppl3):39-47. FI: 1.231 (Q3) Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy Rivas N, Buelga DS, Elger CE, Santos-Borbujo J, Otero MJ, Domínguez-Gil A, García MJ. Therapeutic Drug Monitoring 30(4):483-489. FI: 2.429 (Q1)
|
